Medications are the first-line treatment for atrial fibrillation, or A-fib. When they begin to fail, one option is ablation.

Pulsed field ablation (PFA) has been embraced as a catheter ablation modality with potential to be safer for atrial ...

Abbott’s Volt pulsed field ablation system — for the treatment of atrial fibrillation. The Volt system delivers high-energy electrical pulses to targeted areas of the heart to disrupt abnormal rhythms ...

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...

Abbott (NYSE: ABT) announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with AFib.

Abbott Laboratories (NYSE:ABT) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 22, Abbott ...

After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an | With the U.

It is expected that within the next 20 years that 20 million-60 million people will get atrial fibrillation, usually just called AFib. People with AFib have a five-times increased risk of stroke ...

Pulsed field ablation (PFA) technology made some advances with 12-month results for the Globe Pulsed Field System in paroxysmal atrial fibrillation (Afib). In the single-arm PULSAR IDE study of 162 ...

Lakeway attorney David Wright, 72, had dizzy spells for years, but none of his doctors found the source. Last year, when he was jogging, he noticed his heart rate, which was usually in the 50s, went ...

Successful catheter ablation resulted in a low risk of stroke associated with atrial fibrillation (AFib), a type of irregular heart rhythm, according to an international study. Researchers said these ...